Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Similar articles for PubMed (Select 23898855)

1.

Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.

Han C, Wang SM, Kato M, Lee SJ, Patkar AA, Masand PS, Pae CU.

Expert Rev Neurother. 2013 Jul;13(7):851-70. doi: 10.1586/14737175.2013.811901. Review.

PMID:
23898855
2.

Augmentation treatments with second-generation antipsychotics to antidepressants in treatment-resistant depression.

Kato M, Chang CM.

CNS Drugs. 2013 May;27 Suppl 1:S11-9. doi: 10.1007/s40263-012-0029-7. Review.

PMID:
23709358
3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
4.

Second-generation antipsychotics for major depressive disorder and dysthymia.

Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008121. doi: 10.1002/14651858.CD008121.pub2. Review.

PMID:
21154393
5.

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN.

CNS Spectr. 2009 Apr;14(4):197-206.

PMID:
19407731
6.

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.

Connolly KR, Thase ME.

Drugs. 2011 Jan 1;71(1):43-64. doi: 10.2165/11587620-000000000-00000. Review.

PMID:
21175239
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.

Therapeutic potential of new second generation antipsychotics for major depressive disorder.

McElroy SL, Guerdjikova A, Mori N, Keck PE Jr.

Expert Opin Investig Drugs. 2010 Dec;19(12):1527-44. doi: 10.1517/13543784.2010.538048. Review.

PMID:
21105856
9.

Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.

Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G.

Ann Pharmacother. 2012 May;46(5):642-9. doi: 10.1345/aph.1Q326. Epub 2012 May 1.

PMID:
22550279
10.

The under-recognized role of dopamine in the treatment of major depressive disorder.

Montgomery SA.

Int Clin Psychopharmacol. 2008 Mar;23(2):63-9. doi: 10.1097/YIC.0b013e3282f2b3cb. Review.

PMID:
18301120
11.

Second-generation antipsychotics in major depressive disorder: update and clinical perspective.

Chen J, Gao K, Kemp DE.

Curr Opin Psychiatry. 2011 Jan;24(1):10-7. doi: 10.1097/YCO.0b013e3283413505. Review.

PMID:
21088586
12.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
13.

Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.

Lin CY, Tsai GE, Wang HS, Wu YH, Chiou CC, Wu VY, Lane HY.

J Clin Psychiatry. 2014 Sep;75(9):e924-31. doi: 10.4088/JCP.13m08843.

PMID:
25295435
14.

The efficacy and tolerability of bupropion in the treatment of major depressive disorder.

Moreira R.

Clin Drug Investig. 2011 Oct 19;31 Suppl 1:5-17. doi: 10.2165/1159616-S0-000000000-00000. Review.

PMID:
22015858
15.

Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.

Wright BM, Eiland EH 3rd, Lorenz R.

Pharmacotherapy. 2013 Mar;33(3):344-59. doi: 10.1002/phar.1204. Review.

PMID:
23456734
16.

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.

Papakostas GI.

J Clin Psychiatry. 2009;70 Suppl 6:16-25. doi: 10.4088/JCP.8133su1c.03. Review.

PMID:
19922740
17.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
18.

The role of antipsychotics in the management of fibromyalgia.

Calandre EP, Rico-Villademoros F.

CNS Drugs. 2012 Feb 1;26(2):135-53. doi: 10.2165/11597130-000000000-00000. Review. Erratum in: CNS Drugs. 2013 Jun;27(6):491.

PMID:
22296316
19.

Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.

Pae CU, Forbes A, Patkar AA.

CNS Drugs. 2011 Feb;25(2):109-27. doi: 10.2165/11538980-000000000-00000. Review.

PMID:
21254788
20.

Oral scopolamine augmentation for major depression.

Han C, Pae CU.

Expert Rev Neurother. 2013 Jan;13(1):19-21. doi: 10.1586/ern.12.150.

PMID:
23253388
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk